Modeling codelivery of CD73 inhibitor and dendritic cell-based vaccines in cancer immunotherapy.
Sign Up to like & getrecommendations! Published in 2021 at "Computational biology and chemistry"
DOI: 10.1016/j.compbiolchem.2021.107585
Abstract: Dendritic cells (DCs) are the dominant class of antigen-presenting cells in humans; therefore, a range of DC-based approaches have been established to promote an immune response against cancer cells. The efficacy of DC-based immunotherapeutic approaches… read more here.
Keywords: immunotherapy; cd73 inhibitor; codelivery cd73; model ... See more keywords